Endemic Mycoses: Blastomycosis, Histoplasmosis, and Sporotrichosis

Infectious Disease Clinics of North America

Volumn 20, Issue 3, 2006, Pages 645-662

  Kauffman, Carol A ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; POSACONAZOLE; POTASSIUM IODIDE; VORICONAZOLE;

BLASTOMYCES DERMATITIDIS; BLASTOMYCOSIS; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; ENDEMIC DISEASE; HISTOPATHOLOGY; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; MYCOSIS; NEPHROTOXICITY; OSTEOARTHROPATHY; PATHOGENESIS; REVIEW; SERODIAGNOSIS; SPOROTHRIX SCHENCKII; SPOROTRICHOSIS;

ANTIFUNGAL AGENTS; BLASTOMYCOSIS; HISTOPLASMOSIS; HUMANS; SPOROTRICHOSIS;

EID: 33748562164     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2006.07.002     Document Type: Review

References (75)

1. Klein B.S., Vergeront J.M., DiSalvo A.F., et al. Two outbreaks of blastomycosis along rivers in Wisconsin: isolation of Blastomyces dermatitidis from riverbank soil and evidence of its transmission along waterways. Am Rev Respir Dis 136 (1987) 1333-1338
2. Baumgardner D.J., Buggy B.P., Mattson B.J., et al. Epidemiology of blastomycosis in a region of high endemicity in North Central Wisconsin. Clin Infect Dis 15 (1992) 629-635
3. Armstrong C.W., Jenkins S.R., Kaufman L., et al. Common-source outbreak of blastomycosis in hunters and their dogs. J Infect Dis 155 (1987) 568-570
4. Cano M.V., Ponce-de-Leon G.F., Tippen S., et al. Blastomycosis in Missouri: epidemiology and risk factors for endemic disease. Epidemiol Infect 131 (2003) 907-914
5. Crampton T.L., Light R.B., Berg G.M., et al. Epidemiology and clinical spectrum of blastomycosis diagnosed at Manitoba hospitals. Clin Infect Dis 34 (2002) 1310-1316
6. Gray N.A., and Baddour L.M. Cutaneous inoculation blastomycosis. Clin Infect Dis 34 (2002) e44-e49
7. Klein B.S., Bradsher R.W., Vergeront J.M., et al. Development of long-term specific cellular immunity after acute Blastomyces dermatitidis infection: assessments following a large point-source outbreak in Wisconsin. J Infect Dis 161 (1990) 97-101
8. Pappas P.G., Threlkeld M.G., Bedsole G.D., et al. Blastomycosis in immunocompromised patients. Medicine (Baltimore) 72 (1993) 311-325
9. Meyer K.C., McManus E.J., and Maki D.G. Overwhelming pulmonary blastomycosis associated with the adult respiratory distress syndrome. N Engl J Med 329 (1993) 1231-1236
10. Pappas P.G. Blastomycosis. Semin Respir Crit Care Med 25 (2004) 113-121
11. Sheflin J.R., Campbell J.A., and Thompson G.P. Pulmonary blastomycosis: findings on chest radiographs in 63 patients. AJR Am J Roentgenol 154 (1990) 1177-1180
12. Saccente M., Abernathy R.S., Pappas P.G., et al. Vertebral blastomycosis with paravertebral abscess: report of eight cases and review of the literature. Clin Infect Dis 26 (1998) 413-418
13. Hanson J.M., Spector G., and El-Mofty S.K. Laryngeal blastomycosis: a commonly missed diagnosis. Report of two cases and review of the literature. Ann Otol Rhinol Laryngol 109 (2000) 281-286
14. Friedman J.A., Wijdicks E.F.M., Fulgham J.R., et al. Meningoencephalitis due to Blastomyces dermatitidis: case report and literature review. Mayo Clin Proc 75 (2000) 403-408
15. Areno J.P., Campbell G.D., and George R.B. Diagnosis of blastomycosis. Semin Respir Infect 12 (1997) 252-262
16. Durkin M., Witt J., LeMonte A., et al. Antigen assay with the potential to aid in the diagnosis of blastomycosis. J Clin Microbiol 42 (2004) 4873-4875
17. Chapman S.W., Bradsher Jr. R.W., Campbell Jr. G.D., et al. Practice guidelines for the management of patients with blastomycosis. Clin Infect Dis 30 (2000) 679-683
18. Dismukes W.E., Bradsher R.W., Cloud G.C., et al. Itraconazo1e therapy for blastomycosis and histoplasmosis. Am J Med 93 (1992) 489-497
19. Pappas P.G., Bradsher R.W., Chapman S.W., et al. Treatment of blastomycosis with fluconazole: a pilot study. Clin Infect Dis 20 (1995) 267-271
20. Pappas P.G., Bradsher R.W., Kauffman C.A., et al. Treatment of blastomycosis with higher doses of fluconazole. Clin Infect Dis 25 (1997) 200-205
21. Lentnek A.L., and Lentnek I.A. Successful management of Blastomyces dermatitidis meningitis. Infect Med 23 (2006) 39-41
22. Bakleh M., Aksamit A.J., Tleyjeh I.M., et al. Successful treatment of cerebral blastomycosis with voriconazole. Clin Infect Dis 40 (2005) e69-e71
23. Perfect J.R., Marr K.A., Walsh T.J., et al. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis 36 (2003) 1122-1131
24. Cano M., and Hajjeh R.A. The epidemiology of histoplasmosis: a Review. Semin Respir Infect 16 (2001) 109-118
25. Wheat J. Histoplasmosis. Experience during outbreaks in Indianapolis and review of the literature. Medicine (Baltimore) 76 (1997) 339-354
26. Newman S.L. Cell-mediated immunity to Histoplasma capsulatum. Semin Respir Infect 16 (2001) 102-108
27. Wheat L.J., Conces D., Allen S.D., et al. Pulmonary histoplasmosis syndromes: recognition, diagnosis, and management. Semin Respir Crit Care Med 25 (2004) 129-144
28. Gurney J.W., and Conces D.J. Pulmonary histoplasmosis. Radiology 199 (1996) 297-306
29. Picardi J.L., Kauffman C.A., Schwarz J., et al. Pericarditis caused by Histoplasma capsulatum. Am J Cardiol 37 (1976) 82-88
30. Goodwin R.A., Loyd J.E., and Des Prez R.M. Histoplasmosis in normal hosts. Medicine (Baltimore) 60 (1981) 231-266
31. Davis A., Pierson D., and Loyd J.E. Mediastinal fibrosis. Semin Respir Infect 16 (2001) 119-130
32. Goodwin R.A., Owens F.T., Snell J.D., et al. Chronic pulmonary histoplasmosis. Medicine (Baltimore) 55 (1976) 413-452
33. Goodwin R.A., Shapiro J.L., Thurman G.H., et al. Disseminated histoplasmosis: clinical and pathologic correlations. Medicine (Baltimore) 59 (1980) 1-33
34. McKinsey D.S., Spiegel R.A., Hutwagner L., et al. Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: incidence, risk factors, and pathophysiology. Clin Infect Dis 24 (1997) 1195-1203
35. Wood K.L., Hage C.A., Knos K.S., et al. Histoplasmosis after treatment with anti-TNF-(alpha) therapy. Am J Respir Crit Care Med 167 (2003) 1279-1282
36. Lamps L.W., Molina C.P., West B., et al. The pathologic spectrum of gastrointestinal and hepatic histoplasmosis. Am J Clin Pathol 113 (2000) 64-72
37. Wheat L.J., Musial C.E., and Jenny-Avital E. Diagnosis and management of central nervous system histoplasmosis. Clin Infect Dis 40 (2005) 844-852
38. Kauffman C.A. Histoplasmosis. In: Dismukes W.E., Pappas P.G., and Sobel J.D. (Eds). Clinical mycology (2003), Oxford University Press 285-298
39. Wheat L.J. Laboratory diagnosis of histoplasmosis: a review. Semin Respir Infect 16 (2001) 131-140
40. Wheat L.J., Garringer T., Brizendine E., et al. Diagnosis of histoplasmosis by antigen detection based upon experience at the histoplasmosis reference laboratory. Diagn Microbiol Infect Dis 43 (2002) 29-37
41. Bracca A., Tosello M.E., Girardini J.E., et al. Molecular detection of Histoplasma capsulatum var. capsulatum in human clinical samples. J Clin Microbiol 41 (2003) 1753-1755
42. Bialek R., Feucht A., Aepinus C., et al. Evaluation of two nested PCR assays for detection of Histoplasma capsulatum DNA in human tissue. J Clin Microbiol 40 (2002) 1644-1647
43. Wheat J., Sarosi G., McKinsey D., et al. Practice guidelines for the management of patients with histoplasmosis. Clin Infect Dis 30 (2000) 688-695
44. Dismukes W.E., Bradsher Jr. R.W., Cloud G.C., et al. Itraconazole therapy for blastomycosis and histoplasmosis. Am J Med 93 (1992) 489-497
45. Wheat J., Hafner R., Korzun A.H., et al. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Med 98 (1995) 336-342
46. McKinsey D.S., Kauffman C.A., Pappas P.G., et al. Fluconazole therapy for histoplasmosis. Clin Infect Dis 23 (1996) 996-1001
47. Wheat J., Mawhinney S., Hafner R., et al. Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. Am J Med 103 (1997) 223-232
48. Freifeld A.G., Iwen P.C., Lesiak B.L., et al. Histoplasmosis in solid organ transplant recipients at a large midwestern transplant center. Transplant Infect Dis 7 (2005) 109-115
49. Clark B., Foster R., Tunbridge A., et al. A case of disseminated histoplasmosis successfully treated with the investigational drug posaconazole. J Infect 51 (2005) e177-e180
50. Restrepo A, Tobon A, Clark B, et al. Salvage treatment of histoplasmosis with posaconazole. J Infect, in press.
51. Doyle T.P., Loyd J.E., and Robbins I.M. Percutaneous pulmonary artery and vein stenting: a novel treatment for mediastinal fibrosis. Am J Respir Crit Care Med 164 (2001) 657-660
52. Johnson P.C., Wheat L.J., Cloud G.A., et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med 137 (2002) 105-109
53. Goldman M., Zackin R., Fichtenbaum C.J., et al. Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy. Clin Infect Dis 38 (2004) 1485-1489
54. McKinsey D.S., Wheat L.J., Cloud G., et al. Itraconazole prophylaxis against fungal infections in patients with advanced human immunodeficiency virus infection: randomized placebo-controlled double-blind study. Clin Infect Dis 28 (1999) 1049-1056
55. Kauffman C.A. Sporotrichosis. Clin Infect Dis 29 (1999) 231-237
56. Dixon D.M., Salkin I.F., Duncan R.A., et al. Isolation and characterization of Sporothrix schenckii from clinical and environmental sources associated with the largest US epidemic of sporotrichosis. J Clin Microbiol 29 (1991) 1106-1113
57. Hajjeh R., McDonnell S., Reef S., et al. Outbreak of sporotrichosis among tree nursery workers. J Infect Dis 176 (1997) 499-504
58. Dooley D.P., Bostic P.S., and Beckius M.L. Spook house sporotrichosis. A point-source outbreak of cutaneous sporotrichosis from hay bale props in a Halloween haunted-house. Arch Intern Med 157 (1997) 1885-1887
59. Reed K.D., Moore F.M., Geiger G.E., et al. Zoonotic transmission of sporotrichosis: case report and review. Clin Infect Dis 16 (1993) 384-387
60. Barros M.B.L., Schubach A.A.O., Valle A.C.F., et al. Cat-transmitted sporotrichosis epidemic in Rio de Janeiro, Brazil: description of a series of cases. Clin Infect Dis 38 (2004) 529-535
61. Kwon-Chung K.J. Comparison of isolates of Sporothrix schenckii obtained from fixed cutaneous lesions with isolates from other types of lesions. J Infect Dis 139 (1979) 424-431
62. Pappas P.G., Tellez I., Deep A.E., et al. Sporotrichosis in Peru: description of an area of hyperendemicity. Clin Infect Dis 30 (2000) 65-70
63. Bolao F., Podzamczer D., Ventin M., et al. Efficacy of acute phase and maintenance therapy with itraconazole in an AIDS patient with sporotrichosis. Eur J Clin Microbiol Infect Dis 13 (1994) 609-612
64. Gottlieb G.S., Lesser C.F., Holmes K.K., et al. Disseminated sporotrichosis associated with treatment with immunosuppressants and tumor necrosis factor-alpha antagonists. Clin Infect Dis 37 (2003) 638-640
65. Smego R.A., Castiglia M., and Asperilla M.O. Lymphocutaneous syndrome. A review of non-Sporothrix causes. Medicine (Baltimore) 78 (1999) 38-63
66. Atdjian M., Granda J.L., Ingberg H.O., et al. Systemic sporotrichosis polytenosynovitis with median and ulnar nerve entrapment. JAMA 243 (1980) 1841-1842
67. Pluss J.L., and Opal S.M. Pulmonary sporotrichosis: review of treatment and outcome. Medicine (Baltimore) 65 (1986) 143-153
68. Al-Tawfiq J.A., and Wools K.K. Disseminated sporotrichosis and Sporothrix schenckii fungemia as the initial presentation of human immunodeficiency virus infection. Clin Infect Dis 26 (1998) 1403-1406
69. Kauffman C.A., Hajjeh R., and Chapman S.W. Practice guidelines for the management of patients with sporotrichosis. Clin Infect Dis 30 (2000) 684-687
70. Sharkey-Mathis P.K., Kauffman C.A., Graybill J.R., et al. Treatment of sporotrichosis with itraconazole. Am J Med 95 (1993) 279-285
71. Restrepo A., Robledo J., Gomez I., et al. Itraconazole therapy in lymphangitic and cutaneous sporotrichosis. Arch Dermatol 122 (1986) 413-417
72. Kauffman C.A., Pappas P.G., McKinsey D.S., et al. Treatment of lymphocutaneous and visceral sporotrichosis with fluconazole. Clin Infect Dis 22 (1996) 46-50
73. -1) in the treatment of cutaneous or lymphocutaneous sporotrichosis. Mycoses 47 (2003) 62-68
74. Kauffman C.A. Old and new therapies for sporotrichosis. Clin Infect Dis 21 (1995) 981-985
75. Hiruma M., Kawada A., Noguchi H., et al. Hyperthermic treatment of sporotrichosis: experimental use of infrared and far infrared rays. Mycoses 35 (1992) 293-299